\n
![\"Get](\"https:\/\/stockchase.com\/discover\/wp-content\/uploads\/2019\/11\/premium-button.png\")
<\/a><\/center><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n
Markets were already rebounding Tuesday after Monday’s sharp sell-off when U.S. Federal Gov. Brainard<\/a> called for large-scale asset purchases by the U.S. central bank in the mid-afternoon. Dow the rallied into the close at 2.14% while the S&P rose 1.34% and the Nasdaq lagged just under 1% after selling off for most of the day.<\/p>\n Temporarily, investors set aside worries over new cases of COVID-19 that continue to grip sunbelt states like California and Florida. Meanwhile, Wall Street saw the banks<\/a> release their Q2 reports and the news was concerning. JPMorgan<\/a> warned of double-digit U.S. unemployment through the first half of 2021. The stock actually rose 0.57% after beating on EPS and revenue. However, Wells Fargo<\/a> announced it was slashing its dividend and that earnings and revenue badly missed expectations; its shares plunged 4.57%. Citigroup<\/a> narrowly missed earnings, though it beat on revenues. Nonetheless, shares slid 3.93%.<\/p>\n Things were sunnier in Toronto with the TSX rallying 1.72%, led by energy (up 3.8%), materials (3%) and financials (1.15%). Barrick Gold<\/a> jumped 3.54% and Enbridge<\/a> climbed. But the biggest news came from Immunovaccine<\/a>, a small-cap biotech from Dartmouth, which announced it will start phase 1 trials of its COVID-19 vaccine<\/a>. (There are three trials, which each successive trial testing the drug on exponentially more people.) IMV soared nearly 57%.<\/p>\n 🏛 Wells Fargo<\/a> -4.57% This week, you missed Past Top Picks comments by Fabrice Taylor\u00a0including Aecon Group Inc (A Top Pick Sep 07\/18, Up 18%) Get Premium to receive all past top picks opinions a few hours before market open. Markets were already rebounding […]<\/p>\n","protected":false},"author":12,"featured_media":174836,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cwp_meta_box_check":"No","cwp_rev_product_name":"","cwp_rev_product_image":"","wppr_links":[],"cwp_rev_price":"","wppr_options":[],"wppr_pros":[],"wppr_cons":[],"footnotes":""},"categories":[178],"tags":[],"class_list":["post-178984","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-daily"],"wppr_data":{"cwp_meta_box_check":"No"},"_links":{"self":[{"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/posts\/178984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/comments?post=178984"}],"version-history":[{"count":0,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/posts\/178984\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/media\/174836"}],"wp:attachment":[{"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/media?parent=178984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/categories?post=178984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/tags?post=178984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n🏛 Citigroup Inc.<\/a> -3.93%
\n🥇 Barrick Gold<\/a> +3.54%
\n🛢 Enbridge<\/a> +3.32%<\/p>\n","protected":false},"excerpt":{"rendered":"